Evidence for kinase inhibitor activity in acute myeloid leukaemia
1 Mga view
• 07/04/23
0
0
I-embed
administrator
Mga subscriber
Visit http://www.ecancer.org for more
Dr Ehninger (University Hospital Dresden, Dresden, Germany) talks to ecancertv at EHA 2015 about the results of a phase II randomised study on the safety and efficacy of sorafenib in leukaemia.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento